Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Gastrointestinal 6Genitourinary 4CNS 3Thoracic 2Lymphoid 2Gynecologic 2Tumor-Agnostic 1Sarcoma 1Other hematologic neoplasm 1Head & Neck 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1

Interventions

Specimen Handling 36Magnetic Resonance Spectroscopy 31Cyclophosphamide 26Doxorubicin 23Biopsy 22pembrolizumab 21Temozolomide 21X-Rays 17Radiotherapy 17Radiation 16Nivolumab 13atezolizumab 12Vincristine 12Phantoms, Imaging 12Irinotecan 12Ifosfamide 12Gemcitabine 12fludarabine 11cabozantinib 10liposomal doxorubicin 8Surgical Procedures, Operative 8Ipilimumab 8Etoposide 8Bevacizumab 8Paclitaxel 7Immunoglobulin G 7Carboplatin 7palbociclib 6olaparib 6fludarabine phosphate 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Magnetic Resonance Imaging × Sarcoma × 90 days × Clear all
NCT03054792 2026-04-29

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

The Hospital for Sick Children

Phase 1 Enrolling by invitation
18 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡